- Home
- SUPN vs NUV Comparison
SUPN vs NUV Comparison
Compare SUPN & NUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUPN
- NUV
- Stock Information
- Founded
- SUPN 2005
- NUV 1987
- Country
- SUPN United States
- NUV United States
- Employees
- SUPN N/A
- NUV N/A
- Industry
- SUPN Biotechnology: Pharmaceutical Preparations
- NUV Trusts Except Educational Religious and Charitable
- Sector
- SUPN Health Care
- NUV Finance
- Exchange
- SUPN Nasdaq
- NUV Nasdaq
- Market Cap
- SUPN 2.0B
- NUV 1.8B
- IPO Year
- SUPN 2012
- NUV N/A
- Fundamental
- Price
- SUPN $35.66
- NUV $8.67
- Analyst Decision
- SUPN Hold
- NUV
- Analyst Count
- SUPN 1
- NUV 0
- Target Price
- SUPN $36.00
- NUV N/A
- AVG Volume (30 Days)
- SUPN 285.1K
- NUV 464.9K
- Earning Date
- SUPN 11-04-2024
- NUV 01-01-0001
- Dividend Yield
- SUPN N/A
- NUV 3.96%
- EPS Growth
- SUPN 130.79
- NUV N/A
- EPS
- SUPN 1.07
- NUV N/A
- Revenue
- SUPN $651,972,000.00
- NUV N/A
- Revenue This Year
- SUPN $7.82
- NUV N/A
- Revenue Next Year
- SUPN N/A
- NUV N/A
- P/E Ratio
- SUPN $34.11
- NUV N/A
- Revenue Growth
- SUPN 6.79
- NUV N/A
- 52 Week Low
- SUPN $25.53
- NUV $7.86
- 52 Week High
- SUPN $39.37
- NUV $9.08
- Technical
- Relative Strength Index (RSI)
- SUPN 48.87
- NUV 32.45
- Support Level
- SUPN $35.68
- NUV $8.87
- Resistance Level
- SUPN $37.35
- NUV $8.94
- Average True Range (ATR)
- SUPN 1.01
- NUV 0.07
- MACD
- SUPN -0.18
- NUV -0.02
- Stochastic Oscillator
- SUPN 21.65
- NUV 3.75
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. The Company's diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.
About NUV Nuveen Municipal Value Fund Inc.
Nuveen Municipal Value Fund Inc is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal income tax by investing in a portfolio of municipal obligations issued by state and local government authorities or certain U.S. territories.